openPR Logo
Press release

Thyroid Eye Disease (TED) Market Study Explores Industry Growth Toward $3.12 Billion

08-27-2026 01:05 PM CET | Health & Medicine

Press release from: The Business Research Company

Thyroid Eye Disease (TED) Market

Thyroid Eye Disease (TED) Market

The thyroid eye disease (TED) market is positioned for significant expansion in the coming years, driven by advances in treatment options and growing awareness among healthcare providers and patients alike. As novel therapies gain traction and research efforts intensify, the landscape is evolving rapidly, promising improved outcomes for those affected by this challenging condition.

Projected Growth and Market Size of the Thyroid Eye Disease Market
Forecasts suggest that the thyroid eye disease market will reach a valuation of $3.12 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%. This upward trajectory is expected due to several factors, including the increasing use of innovative biologic drugs like teprotumumab, rising investments in autoimmune disease research, and a broader availability of minimally invasive surgical techniques. Additionally, there is a heightened focus on improving patients' quality of life and a growing demand for more personalized therapeutic approaches tailored to TED.

The thyroid eye disease (ted) market size has grown strongly in recent years. It will grow from $2.29 billion in 2025 to $2.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing prevalence of autoimmune thyroid disorders, improved clinical recognition of ted symptoms, wider use of corticosteroid therapies, expansion of ophthalmology services, growing referral rates from endocrinology clinics.

Download a free sample of the thyroid eye disease (ted) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Factors Encouraging Expansion in the Thyroid Eye Disease Market
One significant factor propelling the market is the adoption of targeted biologic therapies, which offer more precise treatment options with potentially fewer side effects. These advanced therapies are transforming patient care by directly addressing the underlying immune mechanisms of TED.
Moreover, the development of combination treatment strategies that integrate medical and surgical interventions is becoming more common. This approach aims to enhance therapeutic effectiveness and provide comprehensive management of the disease, especially in moderate to severe cases.

Leading Corporations Shaping the Thyroid Eye Disease Market
The competitive landscape includes a variety of prominent companies such as Viridian Therapeutics Inc, Tourmaline Bio Inc, Sling Therapeutics Inc, Immunovant Inc, Hoffmann‐La Roche AG, H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Sanofi SA, Alexion Pharmaceuticals Inc, and Septerna Corporation.
In a notable industry move, Amgen Inc., a US-based biotech company, acquired Horizon Therapeutics plc in October 2023. This acquisition is part of Amgen's strategy to broaden its portfolio in rare and inflammatory diseases by leveraging Horizon's specialized therapies, expanding its global reach, and accelerating innovation for sustained growth. Horizon Therapeutics, headquartered in Ireland, is recognized for its focus on rare autoimmune and inflammatory disorders.

View the full thyroid eye disease (ted) market report:
https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Developments and Innovations in the TED Industry
Companies in the TED market are increasingly prioritizing the development of monoclonal antibody therapies, which offer targeted treatment by mimicking the immune system's ability to neutralize specific disease-causing agents. These therapies aim to reduce inflammation, mitigate proptosis (eye bulging), and enhance overall patient health.
For example, in September 2024, Amgen announced that Japan's Ministry of Health, Labour and Welfare approved TEPEZZA (teprotumumab) for treating active thyroid eye disease. TEPEZZA is the first and only FDA-approved medication specifically indicated for TED. This approval marks a critical milestone, providing Japanese patients with a new treatment option that effectively addresses inflammation and other disabling symptoms associated with the condition.

Detailed Segmentation of the Thyroid Eye Disease Market
This market report categorizes the thyroid eye disease sector into various segments for a comprehensive understanding:
1) Treatment Type: Medical, Surgical, and Combination of Medical and Surgical
2) Disease Severity: Mild, Moderate, and Severe
3) Drug Type: Biologics, Small Molecules, and Other Drug Types
4) Route of Administration: Oral, Intravenous, and Subcutaneous
5) End User: Hospitals, Clinics, and Other healthcare settings

Further subcategories include:
- Medical treatments such as corticosteroids, teprotumumab, and antithyroid medications
- Surgical options including orbital decompression surgery, eyelid surgery, and strabismus surgery
- Combination treatments like corticosteroids with orbital decompression or teprotumumab combined with eyelid surgery

Together, these classifications provide a clear view of how the market is structured and where growth opportunities lie.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Thyroid Eye Disease (TED) Market Study Explores Industry Growth Toward $3.12 Billion here

News-ID: 4615126 • Views:

More Releases from The Business Research Company

Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At 5.4% CAGR
Triple Negative Breast Cancer Market Demonstrates Long-Term Growth Potential At …
An in-depth look into the triple negative breast cancer market reveals promising growth and significant advancements in treatment options. As research intensifies and new therapies emerge, this sector is poised for notable expansion and increased innovation in the coming years. Projected Market Growth of the Triple Negative Breast Cancer Market by 2030 The market for triple negative breast cancer is anticipated to experience substantial growth, reaching a valuation of $1.48
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion Through 2030
Treatment-Resistant Depression Market Outlook Signals Expansion To $2.59 Billion …
The treatment-resistant depression market is on track for significant expansion as new therapies and technologies emerge to address persistent challenges in managing this complex condition. With ongoing advancements in personalized medicine and digital health, this sector is expected to evolve rapidly in the coming years. Here's an in-depth look at the market size, key players, influential trends, and detailed segmentation shaping the industry's outlook. Forecast of the Treatment-Resistant Depression Market Size
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR
Traumatic Brain Injuries Assessment Market Report 2026 Market Outlook Supported …
The assessment of traumatic brain injuries (TBI) is a rapidly evolving field, driven by technological advancements and a growing need for precise and timely diagnosis. As healthcare providers seek more effective tools to evaluate brain trauma, the market for TBI assessment is poised for notable expansion. Below is an in-depth look at how this market is expected to develop, the leading players involved, and the trends shaping its future. Traumatic Brain
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Insights Highlight Segment Expansion And Market Leadership
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market Insights Highlig …
The treatment landscape for transthyretin amyloid cardiomyopathy (ATTR-CM) is on the brink of remarkable growth, driven by innovative medical approaches and increased focus on rare diseases. As advancements continue to emerge, this market is set to transform significantly by 2030, offering new hope for patients affected by this challenging cardiac condition. Projected Market Growth of the ATTR-CM Treatment Market The transthyretin amyloid cardiomyopathy treatment market is anticipated to expand dramatically,

All 5 Releases


More Releases for TED

08-25-2026 | Sports
Total Cents
New TED Talk Discusses NIL Money Issues
FOR IMMEDIATE RELEASE https://www.youtube.com/watch?v=4GpcY-mAIRc New TEDx Talk Warns That Sudden Wealth Can Be More Dangerous Than Poverty Without Financial Preparation Financial advisor, author, and University of Virginia professor Tom Henske says today's NIL era reveals a financial lesson every family should understand. WESTPORT, Conn. - August 24, 2026 - Most people spend years learning how to earn money. Few ever learn how to handle it once it arrives. That is the central message of "Sudden
Yasam Ayavefe And Ted Baker Grooming Room Elevate Everyday Grooming
Yasam Ayavefe is often associated with large projects in hospitality and investment, yet one of his most interesting moves sits on a much smaller stage, the barber's chair. Through his leadership role with Ted Baker Grooming Room (www.yasamayavefe.io/ventures/ted-baker-grooming), he has stepped into a part of the service world that is personal, routine, and very direct. Men walk in for a haircut or shave, spend less than an hour in the
Robertson RPO Appoints Ted Pierni as Head of Delivery
TORONTO, Ont., Jan. 23, 2025 -- Robertson RPO, a leading recruitment process outsourcing provider, is pleased to announce the appointment of Ted Pierni as Head of Delivery. Based in Toronto, Ted will lead Robertson RPO's service delivery strategies, ensuring innovative and scalable recruitment solutions that meet clients' evolving needs. With over 25 years of expertise in recruitment strategy and operational excellence, Ted has held leadership roles at prominent organizations, including
Necktie Market Become Attractive Amid High Competition | Burberry, Gucci, Ted Ba …
Latest Study on Industrial Growth of Worldwide Necktie Market 2023-2029. A detailed study accumulated to offer the Latest insights about acute features of the Worldwide Necktie market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and
Museyon And Author Ted Takashima Release History Book - The Wall
Museyon And Author Ted Takashima Release History Book - The Wall Author Ted Takashima is pleased to announce the release of his new political action thriller, The Wall: The Refugees' Path to a New Republic. Released by Museyon in October 2020, the book is already receiving rave reviews from readers and reviewers. Captain Jadon Green has been labeled the Border Butcher after a terrible tragedy between the US military and illegal
01-06-2011 | Arts & Culture
Voices.com
Voices.com Offers Ted Williams A Helping Hand
After hearing about the incredible story of the homeless man with the golden voice, Voices.com is extending an offer to Ted Williams to help him get his voice over career off the ground. “We would like to extend an offer to Mr. Williams for a free Premium membership at Voices.com, which will allow him to audition for voice work posted at the site by casting directors, creative producers and businesses.” Voices.com